Coban, N. And Gulec, C. 2021. ROR-Alpha May Indirectly Regulate Insulin Resistance Related Lipid Metabolism Genes Through miR-19a-3p And miR-26a-5p in Simvastatin Treatment. METABOLISM-CLINICAL AND EXPERIMENTAL , vol.116 , 89.

Coban, N., & Gulec, C., (2021). ROR-Alpha May Indirectly Regulate Insulin Resistance Related Lipid Metabolism Genes Through miR-19a-3p And miR-26a-5p in Simvastatin Treatment. METABOLISM-CLINICAL AND EXPERIMENTAL , vol.116, 89.

Coban, Neslihan, And Çağrı GÜLEÇ. "ROR-Alpha May Indirectly Regulate Insulin Resistance Related Lipid Metabolism Genes Through miR-19a-3p And miR-26a-5p in Simvastatin Treatment," METABOLISM-CLINICAL AND EXPERIMENTAL , vol.116, 89, 2021

Coban, Neslihan And Gulec, Çağrı. "ROR-Alpha May Indirectly Regulate Insulin Resistance Related Lipid Metabolism Genes Through miR-19a-3p And miR-26a-5p in Simvastatin Treatment." METABOLISM-CLINICAL AND EXPERIMENTAL , vol.116, pp.89, 2021

Coban, N. And Gulec, C. (2021) . "ROR-Alpha May Indirectly Regulate Insulin Resistance Related Lipid Metabolism Genes Through miR-19a-3p And miR-26a-5p in Simvastatin Treatment." METABOLISM-CLINICAL AND EXPERIMENTAL , vol.116, p.89.

@article{article, author={Neslihan ÇOBAN And author={Çağrı GÜLEÇ}, title={ROR-Alpha May Indirectly Regulate Insulin Resistance Related Lipid Metabolism Genes Through miR-19a-3p And miR-26a-5p in Simvastatin Treatment}, journal={METABOLISM-CLINICAL AND EXPERIMENTAL}, year=2021, pages={89} }